Larry Kociolek to Clostridium Infections
This is a "connection" page, showing publications Larry Kociolek has written about Clostridium Infections.
Connection Strength
16.906
-
Clostridioides difficile in Children. Infect Dis Clin North Am. 2025 Dec; 39(4):709-725.
Score: 0.773
-
Strategies to prevent Clostridioides difficile infections in acute-care hospitals: 2022 Update. Infect Control Hosp Epidemiol. 2023 04; 44(4):527-549.
Score: 0.656
-
Association Between Clostridium innocuum and Antibiotic-Associated Diarrhea in Adults and Children: A Cross-sectional Study and Comparative Genomics Analysis. Clin Infect Dis. 2023 02 08; 76(3):e1244-e1251.
Score: 0.650
-
Implementation of a Structured Process for Clinically Indicated Testing for Clostridioides difficile Infections in Pediatric Oncology and Stem Cell Transplant. J Pediatr Hematol Oncol Nurs. 2023 May-Jun; 40(3):188-194.
Score: 0.648
-
Identification of Clostridium innocuum hypothetical protein that is cross-reactive with C. difficile anti-toxin antibodies. Anaerobe. 2022 Jun; 75:102555.
Score: 0.612
-
Translational Aspects of the Immunology of Clostridioides difficile Infection: Implications for Pediatric Populations. J Pediatric Infect Dis Soc. 2021 Nov 17; 10(Supplement_3):S8-S15.
Score: 0.597
-
Clostridioides difficile Infection in Children: Research Progress, Pitfalls, and Priorities. J Pediatric Infect Dis Soc. 2021 Nov 17; 10(Supplement_3):S1-S2.
Score: 0.597
-
Recent advances in Clostridioides difficile infection epidemiology, diagnosis and treatment in children. Curr Opin Infect Dis. 2021 10 01; 34(5):527-532.
Score: 0.592
-
Clostridium innocuum: Microbiological and clinical characteristics of a potential emerging pathogen. Anaerobe. 2021 Oct; 71:102418.
Score: 0.584
-
Moving the Needle on Clostridioides difficile Research in Children: A Major Step Forward but Challenges Remain. Clin Infect Dis. 2020 12 17; 71(10):2589-2591.
Score: 0.560
-
Fidaxomicin for the treatment of Clostridioides difficile in children. Future Microbiol. 2020 07; 15:967-979.
Score: 0.545
-
Natural Clostridioides difficile Toxin Immunization in Colonized Infants. Clin Infect Dis. 2020 05 06; 70(10):2095-2102.
Score: 0.537
-
An Infectious Diseases Perspective on Fecal Microbiota Transplantation for Clostridioides difficile Infection in Children. J Pediatric Infect Dis Soc. 2019 Dec 27; 8(6):580-584.
Score: 0.524
-
Clostridioides difficile Whole-Genome Sequencing Reveals Limited Within-Host Genetic Diversity in a Pediatric Cohort. J Clin Microbiol. 2019 09; 57(9).
Score: 0.511
-
Risk factors for Clostridioides (Clostridium) difficile infection following solid organ transplantation in children. Transpl Infect Dis. 2019 Oct; 21(5):e13149.
Score: 0.509
-
Response to: Treatment of (Recurrent) Clostridioides difficile Infections in Children and Adults. J Pediatr Gastroenterol Nutr. 2019 08; 69(2):e58-e59.
Score: 0.509
-
Healthcare provider diagnostic testing practices for identification of Clostridioides (Clostridium) difficile in children: an Emerging Infections Network survey. Infect Control Hosp Epidemiol. 2019 03; 40(3):276-280.
Score: 0.493
-
Correlation between restriction endonuclease analysis and PCR ribotyping for the identification of Clostridioides (Clostridium) difficile clinical strains. Anaerobe. 2018 Dec; 54:1-7.
Score: 0.475
-
Clostridium difficile Whole Genome Sequencing Reveals Limited Transmission Among Symptomatic Children: A Single-Center Analysis. Clin Infect Dis. 2018 07 02; 67(2):229-234.
Score: 0.472
-
Whole-genome analysis reveals the evolution and transmission of an MDR DH/NAP11/106 Clostridium difficile clone in a paediatric hospital. J Antimicrob Chemother. 2018 05 01; 73(5):1222-1229.
Score: 0.467
-
Comparative genomics analysis of Clostridium difficile epidemic strain DH/NAP11/106. Microbes Infect. 2018 04; 20(4):245-253.
Score: 0.459
-
Clostridium difficile infection and commonly used pediatric medications. J Pediatr. 2017 11; 190:287-290.
Score: 0.451
-
Strategies for Optimizing the Diagnostic Predictive Value of Clostridium difficile Molecular Diagnostics. J Clin Microbiol. 2017 05; 55(5):1244-1248.
Score: 0.431
-
Differences in the Molecular Epidemiology and Antibiotic Susceptibility of Clostridium difficile Isolates in Pediatric and Adult Patients. Antimicrob Agents Chemother. 2016 08; 60(8):4896-900.
Score: 0.413
-
Clinical and Microbiologic Assessment of Cases of Pediatric Community-associated Clostridium difficile Infection Reveals Opportunities for Improved Testing Decisions. Pediatr Infect Dis J. 2016 Feb; 35(2):157-61.
Score: 0.399
-
Clinical Utility of Laboratory Detection of Clostridium difficile Strain BI/NAP1/027. J Clin Microbiol. 2016 Jan; 54(1):19-24.
Score: 0.392
-
Risk Factors for Recurrent Clostridium difficile Infection in Children: A Nested Case-Control Study. J Pediatr. 2015 Aug; 167(2):384-9.
Score: 0.380
-
Concomitant Medical Conditions and Therapies Preclude Accurate Classification of Children With Severe or Severe Complicated Clostridium difficile Infection. J Pediatric Infect Dis Soc. 2015 Dec; 4(4):e139-42.
Score: 0.370
-
Is pediatric Clostridium difficile infection associated with prior antibiotic exposure? Future Microbiol. 2014; 9(7):825-8.
Score: 0.346
-
National variability in surveillance, testing, and infection prevention for Clostridium difficile infection in pediatric populations. Am J Infect Control. 2013 Oct; 41(10):933-5.
Score: 0.333
-
Pediatric Infectious Diseases Physicians' Preferences for Management of Clostridioides difficile Infection: An Emerging Infections Network Survey. J Pediatric Infect Dis Soc. 2026 Jan 17; 15(1).
Score: 0.199
-
Phenotypic analysis of various Clostridioides difficile ribotypes reveals consistency among core processes. Appl Environ Microbiol. 2025 07 23; 91(7):e0096425.
Score: 0.192
-
Intestinal bile acids provide a surmountable barrier against C. difficile TcdB-induced disease pathogenesis. Proc Natl Acad Sci U S A. 2023 05 09; 120(19):e2301252120.
Score: 0.165
-
Redefining Clostridioides difficile infection antibiotic response and clinical outcomes. Lancet Infect Dis. 2023 07; 23(7):e259-e265.
Score: 0.164
-
Fecal Microbiota Transplantation for Clostridioides difficile Infection in Immunocompromised Pediatric Patients. J Pediatr Gastroenterol Nutr. 2023 04 01; 76(4):440-446.
Score: 0.162
-
Baseline stool toxin concentration is associated with risk of recurrence in children with Clostridioides difficile infection. Infect Control Hosp Epidemiol. 2023 09; 44(9):1403-1409.
Score: 0.162
-
Stool Toxin Concentration Does Not Distinguish Clostridioides difficile Infection from Colonization in Children Less Than 3 Years of Age. J Pediatric Infect Dis Soc. 2022 Oct 25; 11(10):454-458.
Score: 0.159
-
Clostridioides difficile Infection in Hospitalized Pediatric Patients: Comparisons of Epidemiology, Testing, and Treatment from 2013 to 2019. J Pediatr. 2023 01; 252:111-116.e1.
Score: 0.157
-
Pediatric research priorities in healthcare-associated infections and antimicrobial stewardship. Infect Control Hosp Epidemiol. 2021 05; 42(5):519-522.
Score: 0.139
-
Safety and Pharmacokinetic Study of Fidaxomicin in Children With Clostridium difficile-Associated Diarrhea: A Phase 2a Multicenter Clinical Trial. J Pediatric Infect Dis Soc. 2018 Aug 17; 7(3):210-218.
Score: 0.119